Guillain-Barre Syndrome and COVID-19 Vaccine: A Report of Nine Patients

• DOI: 10.32598/bcn.2021.3565.1
• Publication Date: 2021-10-31T08:11:00Z
• Authors: Narges Karimi; Reza Boostani; ; Farzad Fatehi; ; Akram Panahi; ; Ali Asghar Okhovat; ; Bentolhoda Ziaadini; ; Keivan Basiri; ; Siamak Abdi; ; Farnaz Sinaei; ; Mojtaba Rezaei; ; Gholamreza Shamsaei; ; Behnaz Ansari; ; Shahriar Nafissi
• Keywords: 2019-20 coronavirus outbreak

Guillain-Barre Syndrome (GBS) is an autoimmune acute inflammatory demyelinating polyneuropathy usually elicited by upper respiratory tract infection. Several studies reported GBS associated with Coronavirus Disease 2019 (COVID-19) In this study, we described nine patients following the COVID-19 vaccine.